Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases
Cardiovascular disease (CVD) stands as the primary cause of global mortality, necessitating early diagnosis for mitigating death rates and improving quality of life. Conventional CVD diagnostic techniques necessitate the use of bulky hospital instruments for electrocardiogram recording and immunoass...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Sensing and Bio-Sensing Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214180425000133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832583875689185280 |
|---|---|
| author | Wenjun Ming Yidan Zhu Wenjun Jiang Jing Zhang Jinxia Liu Li Wu Yuling Qin |
| author_facet | Wenjun Ming Yidan Zhu Wenjun Jiang Jing Zhang Jinxia Liu Li Wu Yuling Qin |
| author_sort | Wenjun Ming |
| collection | DOAJ |
| description | Cardiovascular disease (CVD) stands as the primary cause of global mortality, necessitating early diagnosis for mitigating death rates and improving quality of life. Conventional CVD diagnostic techniques necessitate the use of bulky hospital instruments for electrocardiogram recording and immunoassay, resulting in time-consuming and inconvenient limitations. Point-of-care testing (POCT) presents unique benefits compared to traditional central laboratory (CLT) methods, such as accelerated turnaround times for results, enhanced portability, and ease of use, which are especially beneficial in resource-constrained healthcare environments. As a result, POCT is increasingly recognized as an innovative diagnostic strategy for the management of CVD, achieving significant standing across a variety of healthcare scenarios. The present review offers a comprehensive overview of the prevailing categories of cardiovascular diseases and emphasizes the diagnostic application of cardiac biomarkers detected through blood tests. The focus of this study is specifically on POCT devices used for the detection of biomarkers related to cardiovascular disease. Additionally, their performance will be compared and evaluated against traditional CLT methods and commercially available equipment. With the growing implementation of hierarchical medical policies and increasing demand for health management services, the market for POCT cardiac biomarkers testing is expected to expand further as a crucial development direction within the field of medicine. |
| format | Article |
| id | doaj-art-ffc2deff14e446119b4412af08794881 |
| institution | Kabale University |
| issn | 2214-1804 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Sensing and Bio-Sensing Research |
| spelling | doaj-art-ffc2deff14e446119b4412af087948812025-01-28T04:14:36ZengElsevierSensing and Bio-Sensing Research2214-18042025-02-0147100747Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseasesWenjun Ming0Yidan Zhu1Wenjun Jiang2Jing Zhang3Jinxia Liu4Li Wu5Yuling Qin6School of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Nantong University, Nantong 226019, PR ChinaSchool of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Nantong University, Nantong 226019, PR China; Medical School, Nantong University, Nantong, Jiangsu 226001, PR ChinaSchool of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Nantong University, Nantong 226019, PR ChinaSchool of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Nantong University, Nantong 226019, PR ChinaSchool of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Nantong University, Nantong 226019, PR China; Corresponding authors.School of Life Science, Nantong University, Nantong, Jiangsu 226019, PR China; Corresponding authors.School of Public Health, Nantong Key Laboratory of Public Health and Medical Analysis, Nantong University, Nantong 226019, PR China; Corresponding authors.Cardiovascular disease (CVD) stands as the primary cause of global mortality, necessitating early diagnosis for mitigating death rates and improving quality of life. Conventional CVD diagnostic techniques necessitate the use of bulky hospital instruments for electrocardiogram recording and immunoassay, resulting in time-consuming and inconvenient limitations. Point-of-care testing (POCT) presents unique benefits compared to traditional central laboratory (CLT) methods, such as accelerated turnaround times for results, enhanced portability, and ease of use, which are especially beneficial in resource-constrained healthcare environments. As a result, POCT is increasingly recognized as an innovative diagnostic strategy for the management of CVD, achieving significant standing across a variety of healthcare scenarios. The present review offers a comprehensive overview of the prevailing categories of cardiovascular diseases and emphasizes the diagnostic application of cardiac biomarkers detected through blood tests. The focus of this study is specifically on POCT devices used for the detection of biomarkers related to cardiovascular disease. Additionally, their performance will be compared and evaluated against traditional CLT methods and commercially available equipment. With the growing implementation of hierarchical medical policies and increasing demand for health management services, the market for POCT cardiac biomarkers testing is expected to expand further as a crucial development direction within the field of medicine.http://www.sciencedirect.com/science/article/pii/S2214180425000133Cardiovascular disease (CVD)Point-of-care testing (POCT)BiosensorsCardiovascular biomarkersCommercial diagnostic devices |
| spellingShingle | Wenjun Ming Yidan Zhu Wenjun Jiang Jing Zhang Jinxia Liu Li Wu Yuling Qin Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases Sensing and Bio-Sensing Research Cardiovascular disease (CVD) Point-of-care testing (POCT) Biosensors Cardiovascular biomarkers Commercial diagnostic devices |
| title | Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases |
| title_full | Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases |
| title_fullStr | Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases |
| title_full_unstemmed | Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases |
| title_short | Advanced point-of-care biomarker testing for the diagnosis of cardiovascular diseases |
| title_sort | advanced point of care biomarker testing for the diagnosis of cardiovascular diseases |
| topic | Cardiovascular disease (CVD) Point-of-care testing (POCT) Biosensors Cardiovascular biomarkers Commercial diagnostic devices |
| url | http://www.sciencedirect.com/science/article/pii/S2214180425000133 |
| work_keys_str_mv | AT wenjunming advancedpointofcarebiomarkertestingforthediagnosisofcardiovasculardiseases AT yidanzhu advancedpointofcarebiomarkertestingforthediagnosisofcardiovasculardiseases AT wenjunjiang advancedpointofcarebiomarkertestingforthediagnosisofcardiovasculardiseases AT jingzhang advancedpointofcarebiomarkertestingforthediagnosisofcardiovasculardiseases AT jinxialiu advancedpointofcarebiomarkertestingforthediagnosisofcardiovasculardiseases AT liwu advancedpointofcarebiomarkertestingforthediagnosisofcardiovasculardiseases AT yulingqin advancedpointofcarebiomarkertestingforthediagnosisofcardiovasculardiseases |